MedTrace Logo

Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging

NCT07637266 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-09

No results posted yet for this study

Summary

Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.

Conditions

  • CABG
  • Myocardial Viability

Interventions

DRUG

Del Nido Cardioplegia Solution for myocardial protection

CABG patients receiving Del Nido cardioplegia as the myocardial protection strategy

DRUG

Blood Cardioplegia Solution for myocardial protection

Patients will receive Blood Cardioplegia Solution for myocardial protection

Sponsors & Collaborators

  • Klinički Bolnički Centar Zagreb

    lead OTHER

Principal Investigators

  • Hrvoje Gasparovic · Clinical Hospital Centre Zagreb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-06-01
Completion
2027-06-01

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07637266 on ClinicalTrials.gov